Ausgabe 4/2000
Inhalt (7 Artikel)
Serum amyloid A – an indicator of inflammation in ankylosing spondylitis
U. Lange, B. Boss, J. Teichmann, H. U. Klör, G. Neeck
Basic FGF-induced activation of telomerase in rheumatoid synoviocytes
H. Tsumuki, T. Hasunuma, T. Kobata, T. Kato, A. Uchida, K. Nishioka
Clinical associations and characterisation of antineutrophil cytoplasmic antibodies directed against bactericidal/permeability-increasing protein and azurocidin
T. Cooper, J. Savige, L. Nassis, B. Paspaliaris, P. Neeson, J. Neil, K. R. Knight, M. Daskalakis, J. C. G. Doery
TNF-α gene polymorphism does not affect the clinical and radiological outcome of rheumatoid arthritis
J. K. Lacki, R. Moser, I. Korczowska, S. Mackiewicz, W. Muller
Mast cell derangement in salivary glands in patients with Sjögren's syndrome
Y. T. Konttinen, J. Hietanen, I. Virtanen, J. Ma, T. Sorsa, J.-W. Xu, N. P. Williams, R. Manthorpe, A. Janin
Bone marrow CD34+ progenitor cells from rheumatoid arthritis patients support spontaneous transformation of peripheral blood B cells from healthy individuals
S. Hirohata, T. Yanagida, H. Nakamura, S. Yoshino, T. Tomita, T. Ochi
Interleukin-6 serum concentration in ankylosing spondylitis: a reliable predictor of disease progression in the subsequent year?
A. Falkenbach, M. Herold, R. Wigand